NU Skin Enterprises Inc
NYSE:NUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (0.7), the stock would be worth $11.82 (58% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.5 | $7.46 |
0%
|
| 3-Year Average | 0.7 | $11.82 |
+58%
|
| 5-Year Average | 1.3 | $20.5 |
+175%
|
| Industry Average | 1.8 | $28.44 |
+281%
|
| Country Average | 2.5 | $40.31 |
+440%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
NU Skin Enterprises Inc
NYSE:NUS
|
359.6m USD | 0.5 | 2.3 | |
| FR |
|
L'Oreal SA
PAR:OR
|
200.6B EUR | 5.8 | 32.9 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
92.3B GBP | 6.9 | 11.4 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.6T INR | 11.2 | 37.6 | |
| UK |
|
HALEON PLC
LSE:HLN
|
31.3B GBP | 1.9 | 18.7 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
27.6B USD | 6.9 | -155.2 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
16B EUR | 1.8 | 16.9 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 2.5 | 22.2 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR | 9.6 | 64.1 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | -10 713 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
815.9B INR | 7.3 | 43.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.5 |
| 70th Percentile | 4.8 |
| Max | 147 580.5 |
Other Multiples
NU Skin Enterprises Inc
Glance View
Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. The company is headquartered in Provo, Utah and currently employs 4,600 full-time employees. Nu Skin develops and distributes beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands. Nu Skin offers beauty and personal care products that include Body, DR. Dana, Epoch, Nu Colour, Nutricentials, Tri-Phasic White and Tru Face. Pharmanex offers nutritional products, including ageLOC R2, ageLOC Vitality, ageLOC Youth, g3, LifePak, TR90 and S3 Scanner. The firm operates through seven segments, which consists of seven geographic Nu Skin segments, including Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau, and Europe, Middle East and Africa, which includes Europe as well as Israel, Russia and South Africa.
